FDA Approves MIXJECT – A New Delivery System For Treslstar

Watson Pharmaceuticals, Inc. (WPI), announced that the U.S. Food and Drug Administration (FDA) has approved MIXJECT, which is a new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension). The delivery system includes some new features, a smaller 21-gauge needle that should improve comfort and a shield covering the needle both before and after drug [...]